Photo caption: Diabetes care nurses Barbara Weryk, Marsha Driscoll and Mary Biro know first-hand the challenges of using an insulin pump to manage diabetes.
By: Suzanne Elshorafa, St. Joseph’s Health Care London
When patient Matt Griest switched to insulin pump therapy, he had no idea just how life-changing it would be – and how valuable he’d find the support, knowledge and compassion from the Diabetes Care Team at St. Joseph’s Health Care London (St. Joseph’s).
“They provide a wealth of knowledge and extensive resources,” says Griest. “I felt empowered and confident every step of the way.”
The care he received was all the more meaningful because several members of the team have also been where he was.
Barbara Weryk, Marsha Driscoll and Mary Biro are registered nurses and diabetes educators. They all live with type 1 diabetes – and each one wears an insulin pump.
“Most patients just want to know they can live a normal life,” says Driscoll. "Seeing us wear the pump often puts them at ease.”
Griest started receiving care at St. Joseph’s a decade ago and, in consultation with his team and his doctor, recently made the switch to insulin pump therapy.
While insulin pumps are a preferred method for managing type 1 diabetes, a recent clinical trial co-led at St. Joseph’s has revealed their significant benefits for people living with type 2 diabetes who require multiple daily insulin injections.
The team focuses on assuring quality care and compassion by addressing fears, dispelling myths and tailoring care to each patient.
“It’s not my agenda; it’s the patient’s agenda,” says Biro, registered nurse and certified diabetes educator. “We ask permission first, we listen and we work together.”
“Some people worry about relying on technology,” adds Driscoll. “But we’re here to guide them through it, without judgment.”
The research results have shown that people with Type 2 diabetes can benefit from the use of insulin pump therapy and is beneficial in improving the quality of life for people living with diabetes.
“I wish I had made the switch sooner,” Griest says. “My diabetes is now so much better managed.”
Dr. Tamara Spaic, an endocrinologist and Lawson researcher who was Canadian sites lead investigator on the clinical trial, highlights how managing glucose effectively is essential but can still be difficult for many people living with type 2 diabetes.
"With expanding treatment options and new technologies, we now have tools that can improve outcomes and ease the day-to-day burden of self-management,” Spaic says. “Our goal is to bring the benefits of this research into the hands of patients who need it most.”